1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Innovative Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Innovative Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biological Medicine
1.4.3 Chemical Medicine
1.5 Market by Application
1.5.1 Global Innovative Drug Market Share by Application: 2021-2026
1.5.2 Hospitals and Clinics
1.5.3 Pharmacy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Innovative Drug Market
1.8.1 Global Innovative Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Innovative Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Innovative Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Innovative Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Innovative Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Innovative Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Innovative Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Innovative Drug Sales Volume
3.3.1 North America Innovative Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Innovative Drug Sales Volume
3.4.1 East Asia Innovative Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Innovative Drug Sales Volume (2015-2020)
3.5.1 Europe Innovative Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Innovative Drug Sales Volume (2015-2020)
3.6.1 South Asia Innovative Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Innovative Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Innovative Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Innovative Drug Sales Volume (2015-2020)
3.8.1 Middle East Innovative Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Innovative Drug Sales Volume (2015-2020)
3.9.1 Africa Innovative Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Innovative Drug Sales Volume (2015-2020)
3.10.1 Oceania Innovative Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Innovative Drug Sales Volume (2015-2020)
3.11.1 South America Innovative Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Innovative Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Innovative Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Innovative Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Innovative Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Innovative Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Innovative Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Innovative Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Innovative Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Innovative Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Innovative Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Innovative Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Innovative Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Innovative Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Innovative Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Innovative Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Innovative Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Innovative Drug Consumption Volume by Application (2015-2020)
15.2 Global Innovative Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Innovative Drug Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Innovative Drug Product Specification
16.1.3 Pfizer Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Gilead Sciences
16.2.1 Gilead Sciences Company Profile
16.2.2 Gilead Sciences Innovative Drug Product Specification
16.2.3 Gilead Sciences Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson & Johnson
16.3.1 Johnson & Johnson Company Profile
16.3.2 Johnson & Johnson Innovative Drug Product Specification
16.3.3 Johnson & Johnson Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche Innovative Drug Product Specification
16.4.3 Roche Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 AbbVie
16.5.1 AbbVie Company Profile
16.5.2 AbbVie Innovative Drug Product Specification
16.5.3 AbbVie Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Sanofi
16.6.1 Sanofi Company Profile
16.6.2 Sanofi Innovative Drug Product Specification
16.6.3 Sanofi Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Amgen
16.7.1 Amgen Company Profile
16.7.2 Amgen Innovative Drug Product Specification
16.7.3 Amgen Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Novartis
16.8.1 Novartis Company Profile
16.8.2 Novartis Innovative Drug Product Specification
16.8.3 Novartis Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Merck & Co. (MSD)
16.9.1 Merck & Co. (MSD) Company Profile
16.9.2 Merck & Co. (MSD) Innovative Drug Product Specification
16.9.3 Merck & Co. (MSD) Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 GlaxoSmithKline (GSK)
16.10.1 GlaxoSmithKline (GSK) Company Profile
16.10.2 GlaxoSmithKline (GSK) Innovative Drug Product Specification
16.10.3 GlaxoSmithKline (GSK) Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Bayer
16.11.1 Bayer Company Profile
16.11.2 Bayer Innovative Drug Product Specification
16.11.3 Bayer Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Takeda
16.12.1 Takeda Company Profile
16.12.2 Takeda Innovative Drug Product Specification
16.12.3 Takeda Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 AstraZeneca
16.13.1 AstraZeneca Company Profile
16.13.2 AstraZeneca Innovative Drug Product Specification
16.13.3 AstraZeneca Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Novo Nordisk
16.14.1 Novo Nordisk Company Profile
16.14.2 Novo Nordisk Innovative Drug Product Specification
16.14.3 Novo Nordisk Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Teva
16.15.1 Teva Company Profile
16.15.2 Teva Innovative Drug Product Specification
16.15.3 Teva Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Bristol-Myers Squibb
16.16.1 Bristol-Myers Squibb Company Profile
16.16.2 Bristol-Myers Squibb Innovative Drug Product Specification
16.16.3 Bristol-Myers Squibb Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Boehringer Ingelheim
16.17.1 Boehringer Ingelheim Company Profile
16.17.2 Boehringer Ingelheim Innovative Drug Product Specification
16.17.3 Boehringer Ingelheim Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Allergan
16.18.1 Allergan Company Profile
16.18.2 Allergan Innovative Drug Product Specification
16.18.3 Allergan Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Eli Lilly
16.19.1 Eli Lilly Company Profile
16.19.2 Eli Lilly Innovative Drug Product Specification
16.19.3 Eli Lilly Innovative Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Innovative Drug Manufacturing Cost Analysis
17.1 Innovative Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Innovative Drug
17.4 Innovative Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Innovative Drug Distributors List
18.3 Innovative Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Innovative Drug (2021-2026)
20.2 Global Forecasted Revenue of Innovative Drug (2021-2026)
20.3 Global Forecasted Price of Innovative Drug (2015-2026)
20.4 Global Forecasted Production of Innovative Drug by Region (2021-2026)
20.4.1 North America Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Innovative Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Innovative Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Innovative Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Innovative Drug by Country
21.2 East Asia Market Forecasted Consumption of Innovative Drug by Country
21.3 Europe Market Forecasted Consumption of Innovative Drug by Countriy
21.4 South Asia Forecasted Consumption of Innovative Drug by Country
21.5 Southeast Asia Forecasted Consumption of Innovative Drug by Country
21.6 Middle East Forecasted Consumption of Innovative Drug by Country
21.7 Africa Forecasted Consumption of Innovative Drug by Country
21.8 Oceania Forecasted Consumption of Innovative Drug by Country
21.9 South America Forecasted Consumption of Innovative Drug by Country
21.10 Rest of the world Forecasted Consumption of Innovative Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer